Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Phelix Therapeutics

Phelix Therapeutics?uq=w9if130k
2014 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$4.72M LATEST DEAL AMOUNT
2 INVESTORS
Description

Owner and operator of a healthcare company. The company develop therapeutics for the medical needs like SARS, MERS and Ebola.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Services
Other Industries
Other Healthcare
Primary Office
  • 3711 Market Street
  • Philadelphia, PA 19104
  • United States

+1 (215) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Phelix Therapeutics’s full profile, request a free trial.

Phelix Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jul-2015 $4.72M Completed Startup
1. Accelerator/Incubator 27-Apr-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Phelix Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institutes of Health Government 000 0000 000000 0
Science Center Accelerator/Incubator 000 0000 000000 0

Phelix Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
Doron Greenbaum Ph.D Founder & Chief Executive Officer
Kenneth Kovan Vice President, Corporate Development and Operations